Publication:
A Practical Approach to Pharmaceutical Policy

Simple item page
dc.contributor.authorSeiter, Andreas
dc.date.accessioned2012-03-19T09:34:20Z
dc.date.available2012-03-19T09:34:20Z
dc.date.issued2010
dc.description.abstractThis book discusses the wide range of challenges faced by policy makers in the pharmaceutical sector, presents the current know-how in terms of policy measures, and provides specific examples of policy packages that can be used in defined circumstances, even if one assumes a certain degree of political resistance and capacity limits on the side of the implementing agency. This book focuses on developing countries and tries to address the issues faced by both low- and middle-income countries. The book does not cover the vaccines market and its respective policies because too many differences exist between the markets for vaccines and pharmaceuticals to cover both subsectors in one publication of this type. The book ends with an outlook on how things might evolve in the longer term. It assumes that some form of convergence will take place toward "models that work," thus reducing the fragmentation of policies and enhancing regulatory and economic efficiencies over time-one hopes to the benefit of all stakeholders in the sector and, in particular, those who, as patients, currently do not have reliable access to effective and safe medicines.en
dc.identifierhttp://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000334955_20100622050742
dc.identifier.doi10.1596/978-0-8213-8386-5
dc.identifier.isbn978-0-8213-8386-5
dc.identifier.urihttps://hdl.handle.net/10986/2468
dc.languageEnglish
dc.publisherWorld Bank
dc.relation.ispartofseriesDirections in development ; human development
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectABUSE
dc.subjectACCOUNTABILITY
dc.subjectACQUIRED IMMUNODEFICIENCY SYNDROME
dc.subjectBIOLOGICALS
dc.subjectBRAND
dc.subjectBRIBERY
dc.subjectBUDGETING
dc.subjectCANCER
dc.subjectCAPSULES
dc.subjectCARDIOVASCULAR DISEASE
dc.subjectCENTRAL MEDICAL STORES
dc.subjectCHEMISTS
dc.subjectCHILD MORTALITY
dc.subjectCHRONIC DISEASES
dc.subjectCIF
dc.subjectCITIZENS
dc.subjectCITIZENSHIP
dc.subjectCIVIL SOCIETY ORGANIZATIONS
dc.subjectCLINICAL TRIALS
dc.subjectCLINICS
dc.subjectCOMMODITIES
dc.subjectCOMPETITIVE BIDDING
dc.subjectCOMPETITIVENESS
dc.subjectCOMPLICATIONS
dc.subjectCONSUMER GROUPS
dc.subjectCORRUPTION
dc.subjectDEATH RATES
dc.subjectDECISION MAKING
dc.subjectDELIVERY SYSTEMS
dc.subjectDEMOCRACY
dc.subjectDEVELOPING COUNTRIES
dc.subjectDEVELOPMENT GOALS
dc.subjectDEVELOPMENT POLICY
dc.subjectDIABETES
dc.subjectDISABILITY
dc.subjectDISCRIMINATION
dc.subjectDISSEMINATION
dc.subjectDISTRIBUTION SYSTEMS
dc.subjectDOMESTIC MANUFACTURERS
dc.subjectDONOR FINANCING
dc.subjectDOSAGE FORMS
dc.subjectDRUG CONTROL
dc.subjectDRUG DONATIONS
dc.subjectDRUG INDUSTRY
dc.subjectDRUG PRICES
dc.subjectDRUGS
dc.subjectECONOMIC GROWTH
dc.subjectEDUCATION SYSTEMS
dc.subjectEMERGING MARKETS
dc.subjectENVIRONMENTAL PROTECTION
dc.subjectESSENTIAL DRUGS
dc.subjectESSENTIAL MEDICINES
dc.subjectFAMILIES
dc.subjectFAMILY MEMBERS
dc.subjectFAVORITISM
dc.subjectFIXED COSTS
dc.subjectFRAUD
dc.subjectFUTURE GROWTH
dc.subjectGENERIC DRUGS
dc.subjectGLOBAL DEVELOPMENT
dc.subjectGLOBAL POLICY
dc.subjectGMP
dc.subjectGOOD GOVERNANCE
dc.subjectGOOD MANUFACTURING PRACTICES
dc.subjectGOVERNMENT AGENCIES
dc.subjectHEALTH CARE
dc.subjectHEALTH CARE ACCESS
dc.subjectHEALTH CARE PROVIDERS
dc.subjectHEALTH CARE REFORM
dc.subjectHEALTH CARE SYSTEM
dc.subjectHEALTH CENTERS
dc.subjectHEALTH FACILITIES
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH MANAGEMENT
dc.subjectHEALTH OUTCOMES
dc.subjectHEALTH POLICIES
dc.subjectHEALTH POLICY
dc.subjectHEALTH REFORM
dc.subjectHEALTH SECTOR
dc.subjectHEALTH SERVICES
dc.subjectHEALTH SYSTEM
dc.subjectHEALTH SYSTEMS
dc.subjectHEALTH WORKERS
dc.subjectHIGH BLOOD PRESSURE
dc.subjectHIV
dc.subjectHOME COUNTRIES
dc.subjectHOSPITAL
dc.subjectHOSPITALS
dc.subjectHUMAN DEVELOPMENT
dc.subjectHUMAN IMMUNODEFICIENCY VIRUS
dc.subjectILLNESS
dc.subjectILLNESSES
dc.subjectIMMUNIZATION
dc.subjectIMMUNODEFICIENCY
dc.subjectIMPORTED DRUGS
dc.subjectINDUSTRIAL DEVELOPMENT
dc.subjectINDUSTRIAL PRODUCTION
dc.subjectINFORMATION SYSTEMS
dc.subjectINTERMEDIARIES
dc.subjectINTERNATIONAL AGREEMENTS
dc.subjectINTERNATIONAL ORGANIZATIONS
dc.subjectINVENTORY
dc.subjectINVENTORY MANAGEMENT
dc.subjectLABORATORIES
dc.subjectLAWS
dc.subjectLEGAL STATUS
dc.subjectLIFE EXPECTANCY
dc.subjectLOCAL ECONOMY
dc.subjectLOCAL MANUFACTURERS
dc.subjectLOW-INCOME COUNTRIES
dc.subjectLOW-INCOME COUNTRY
dc.subjectMALARIA
dc.subjectMANAGEMENT SYSTEMS
dc.subjectMARKET ENTRY
dc.subjectMARKETING
dc.subjectMEDICAL EDUCATION
dc.subjectMEDICAL NEEDS
dc.subjectMEDICAL SCHOOL
dc.subjectMEDICAL SERVICES
dc.subjectMEDICAL SPECIALISTS
dc.subjectMEDICAL SUPPLIES
dc.subjectMEDICINE
dc.subjectMEDICINES
dc.subjectMILLENNIUM DEVELOPMENT GOALS
dc.subjectMINISTRIES OF HEALTH
dc.subjectMINISTRY OF HEALTH
dc.subjectMORTALITY
dc.subjectNARCOTICS
dc.subjectNATIONAL DRUG
dc.subjectNATIONAL GOVERNMENT
dc.subjectNATIONAL LEGISLATION
dc.subjectNURSE
dc.subjectNURSES
dc.subjectNUTRITION
dc.subjectOPERATING COSTS
dc.subjectPACKAGING
dc.subjectPATIENT
dc.subjectPATIENTS
dc.subjectPAYMENT TERMS
dc.subjectPERSONAL RELATIONSHIPS
dc.subjectPHARMACEUTICAL
dc.subjectPHARMACEUTICAL COMPANIES
dc.subjectPHARMACEUTICAL EXPENDITURE
dc.subjectPHARMACEUTICAL INDUSTRY
dc.subjectPHARMACEUTICAL MANUFACTURERS
dc.subjectPHARMACEUTICAL MARKETING
dc.subjectPHARMACEUTICAL MARKETS
dc.subjectPHARMACEUTICAL POLICIES
dc.subjectPHARMACEUTICAL POLICY
dc.subjectPHARMACEUTICAL PRICING
dc.subjectPHARMACEUTICAL PRICING POLICIES
dc.subjectPHARMACEUTICAL PROCUREMENT
dc.subjectPHARMACEUTICAL PRODUCTS
dc.subjectPHARMACEUTICAL REFORM
dc.subjectPHARMACEUTICAL REGULATION
dc.subjectPHARMACEUTICAL SECTOR
dc.subjectPHARMACEUTICAL SUPPLY
dc.subjectPHARMACEUTICAL ¸ MANUFACTURERS
dc.subjectPHARMACEUTICALS
dc.subjectPHARMACIES
dc.subjectPHARMACISTS
dc.subjectPHARMACOLOGISTS
dc.subjectPHARMACY
dc.subjectPHYSICIANS
dc.subjectPOLICY DECISIONS
dc.subjectPOLICY FRAMEWORK
dc.subjectPOLICY GOALS
dc.subjectPOLICY MAKERS
dc.subjectPOLITICAL CHANGE
dc.subjectPOLITICAL DECISION
dc.subjectPOLITICAL OPPOSITION
dc.subjectPOLITICAL SUPPORT
dc.subjectPOOLED PROCUREMENT
dc.subjectPRACTITIONERS
dc.subjectPRESCRIPTIONS
dc.subjectPRICE REGULATION
dc.subjectPRIVATE PHARMACIES
dc.subjectPROCUREMENT
dc.subjectPROGRESS
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC HEALTH POLICY
dc.subjectPUBLIC POLICY
dc.subjectPUBLIC SUPPORT
dc.subjectPURCHASING
dc.subjectPURCHASING POWER
dc.subjectQUALITY ASSURANCE
dc.subjectQUALITY CONTROL
dc.subjectQUALITY OF CARE
dc.subjectQUANTITATIVE DATA
dc.subjectRATIONAL USE OF DRUGS
dc.subjectREFORM EFFORT
dc.subjectREGULATORY AGENCIES
dc.subjectREGULATORY AUTHORITIES
dc.subjectREGULATORY BARRIERS
dc.subjectRESPECT
dc.subjectRETAIL
dc.subjectRETAIL PHARMACIES
dc.subjectRISK FACTORS
dc.subjectRURAL AREAS
dc.subjectSALES
dc.subjectSECURE SUPPLY
dc.subjectSERVICE DELIVERY
dc.subjectSERVICE PROVIDERS
dc.subjectSERVICE QUALITY
dc.subjectSOCIAL SECURITY
dc.subjectSTOCKS
dc.subjectSUPPLIER
dc.subjectSUPPLIERS
dc.subjectSUPPLY CHAIN
dc.subjectSUPPLY CHAINS
dc.subjectTABLETS
dc.subjectTECHNICAL CAPACITY
dc.subjectTRADE ISSUES
dc.subjectTRANSPORTATION
dc.subjectTUBERCULOSIS
dc.subjectTURNOVER
dc.subjectUNEMPLOYMENT
dc.subjectUNEMPLOYMENT RATES
dc.subjectUNIVERSAL ACCESS
dc.subjectURBAN POPULATION
dc.subjectUSE OF RESOURCES
dc.subjectVACCINES
dc.subjectWAREHOUSE
dc.subjectWAREHOUSES
dc.subjectWHOLESALERS
dc.subjectWORKERS
dc.subjectWORLD HEALTH ORGANIZATION
dc.titleA Practical Approach to Pharmaceutical Policyen
dspace.entity.typePublication
okr.doctypePublications & Research::Publication
okr.doctypePublications & Research::Publication
okr.docurlhttp://www-wds.worldbank.org/external/default/main?menuPK=64187510&pagePK=64193027&piPK=64187937&theSitePK=523679&menuPK=64187510&searchMenuPK=64187283&siteName=WDS&entityID=000334955_20100622050742
okr.globalpracticeMacroeconomics and Fiscal Management
okr.globalpracticeTransport and ICT
okr.globalpracticeFinance and Markets
okr.globalpracticeTrade and Competitiveness
okr.globalpracticeHealth, Nutrition, and Population
okr.guid751541468325451548
okr.identifier.doi10.1596/978-0-8213-8386-5
okr.identifier.externaldocumentum000334955_20100622050742
okr.identifier.internaldocumentum12451666
okr.identifier.report55203
okr.language.supporteden
okr.pdfurlhttp://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2010/06/22/000334955_20100622050742/Rendered/PDF/552030PUB0Phar10Box349442B01PUBLIC1.pdfen
okr.topicPrivate Sector Development::E-Business
okr.topicHealth, Nutrition and Population::Population Policies
okr.topicHealth, Nutrition and Population::Health Monitoring and Evaluation
okr.topicMacroeconomics and Economic Growth::Markets and Market Access
okr.topicHealth, Nutrition and Population::Pharmaceuticals & Pharmacoeconomics
okr.topicHealth, Nutrition and Population
okr.unitHealth
okr.unitNutrition & Popultn Team (HDNHE)
okr.volume1 of 1
relation.isAuthorOfPublication8d6fe777-ecd9-594f-ad71-6caae07af3f6
relation.isAuthorOfPublication.latestForDiscovery8d6fe777-ecd9-594f-ad71-6caae07af3f6
relation.isSeriesOfPublication706db16a-e556-46f0-8283-1b4a4b88645c
relation.isSeriesOfPublication.latestForDiscovery706db16a-e556-46f0-8283-1b4a4b88645c
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
552030PUB0Phar10Box349442B01PUBLIC1.pdf
Size:
2.44 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
552030PUB0Phar10Box349442B01PUBLIC1.txt
Size:
575.3 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Directions in Development